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Conclusion. This dual potential of NAC to inhibit phagocyteAOPP-induced activation of human neutrophil and monocyte
oxidative responses induced by HSA-AOPP without affectingoxidative metabolism: A potential target for N-acetylcysteine
those mediated by compounds mimicking pathogens supportstreatment in dialysis patients.
the proposal of a therapeutic trial with NAC aimed at reducingBackground. Oxidative stress largely contributes to hemodi-
oxidative stress–related inflammation in hemodialysis patients.alysis-associated lethal complications, thus explaining the ur-
gent need of antioxidant-based therapeutic strategies in hemo-
dialysis patients. We previously identified advanced oxidation
protein products (AOPP) in the uremic plasma as exquisite mark- Oxidative stress, resulting from a disruption of the
ers of oxidative stress and potent mediators of monocyte activa- natural balance between pro- and anti-oxidant systemstion. The present study was aimed at searching whether (1)
in favor of the former [1, 2] has long been reported inAOPP can also trigger activation of polymorphonuclear neutro-
patients on maintenance hemodialysis [3]. In these pa-phils (PMN), and (2) whether AOPP-induced activation could
be inhibited by N-acetylcysteine (NAC), a widely used compound tients recurrent blood interaction with bioincompatible
which has been shown to prevent oxidative injury to kidney. dialysis membranes triggers polymorphonuclear neutro-
Methods. Both human serum albumin (HAS) AOPP (i.e., phil (PMN) and monocyte activation and their subsequent
HOCl-modified HSA in vitro preparations and AOPP extracted
generation of highly reactive oxygen species (ROS) in-from plasma of hemodialysis patients) were tested for their
cluding O2 and its derivatives (H2O2, OH and 1O2) viacapacity to trigger phagocyte nicotinamide adenine dinucleotide
nicotinamide adenine dinucleotide phosphate (NADPH)phosphate (NADPH) oxidase and myeloperoxidase (MPO)-
dependent activities as measured by lucigenin- and luminol- oxidase complex and OCl via myeloperoxidase (MPO)-
amplified chemiluminescence (CL), respectively, as compared dependent reaction between chloride and H2O2 [4]. More-to receptor-dependent [opsonized zymosan or receptor-inde- over, the profound impairment in antioxidant systemspendent phorbol myristate acetate (PMA)]. The effect of PMN
as for instance glutathione peroxidase activity [5–8], to-priming by platelet-activating factor (PAF), and the effect of
gether with regular perdialytic loss of antioxidant mole-NAC on normal monocyte and on normal or hemodialysis
patient’s (N  16) PMN oxidative responses were compared. cules (such as glutathione), favor oxidant-mediated dam-
Results. HSA-AOPP triggered in a HOCl dose-dependent age [9].
manner both NADPH-oxidase- and MPO-dependent CL of Evidence for oxidative stress in hemodialysis patients
PMN. This latter was further enhanced by PAF priming. Plasma-
has long relied solely on elevated circulating levels ofderived AOPP obtained from hemodialysis patients also trig-
lipid oxidation markers [10–13]. More recently, increasedgered PMN respiratory burst. NAC significantly reduced HSA-
levels of carbonyl compounds in relation to the forma-AOPP–mediated responses of normal monocyte and of normal
and uremic PMN but had no significant effect on opsonized tion of advanced glycation end products (AGE) have
zymosan- or PMA-induced CL responses. also been reported in these patients [14, 15].
In the search for specific markers of protein oxidation
[16] in the plasma of hemodialysis patients, we recently
Key words: oxidative stress, advanced oxidation protein products, poly- described a novel family of oxidized protein compounds,morphonuclear neutrophils, monocytes, NADPH-oxidase, myeloper-
which we designated advanced oxidation protein prod-oxidase, N-acetylcysteine.
ucts (AOPP) [17] in keeping with their close relationship
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pound. A close correlation was found between AOPP and centration was measured by spectrophotometry using a
molar extinction coefficient of 350 mol1/cm1 at 290 nmcarbonyls or dityrosine levels. This latter observation was
in keeping with the well-documented capacity of HOCl at pH 12. HSA (100 mg/mL) was exposed to HOCl (100
mmol/L) for 30 minutes at room temperature and thento induce the formation of tyrosine products [18]. In a
following study [19] we showed that (1) in vivo AOPP dialyzed overnight against PBS.
AOPP concentrations were measured by a spectro-levels are in fact elevated early in the course of chronic
renal failure (CRF), increase with the progression of photometric assay, as described previously [17]. Briefly,
200 L of AOPP-HSA or HSA preparation in PBS wereCRF and are closely related to monocyte activation state,
and (2) in vitro, HOCl-modified HSA (referred herein placed in a 96-well plate (Nunc-immuno plate, Roskilde,
Denmark) and mixed with 20 L acetic acid. AOPPas HSA-AOPP) also retain the capacity to trigger mono-
cyte respiratory burst, and this was not induced by dityro- concentrations were measured in a microplate reader
MR5000 (Dynatech, Paris, France) at 340 nm and cali-sine alone. Taken together, these findings led us to pro-
pose AOPP as both an ultrasensitive gauge of oxidative brated versus standard reference wells containing 200
L of chloramine-T solution (0 to 100 mol/L), 10 Lstress and a novel class of mediators of inflammation in
CRF [20]. More recently, Himmelfarb and McMonagle of 1.16 mol/L potassium iodide, and 20 L of acetic acid.
The content of AOPP in the stock HSA-AOPP prepara-[21] also concluded that albumin was the major plasma
protein target of oxidative stress in uremia and that its tion used for all experiments in this study was 300
mol/L versus 23 mol/L in native HSA. The concentra-oxidation contributes to the development of cardiovas-
cular risk. tions of dityrosine were 9.6 mol/L versus 0.8 mol/L,
respectively, and those of carbonyls of 20,940 mol/LThe role of oxidative stress in the major dialysis-associ-
ated complications such as amyloidosis and accelerated versus 100 mol/L, respectively.
In an attempt to concentrate high-molecular-weightatherosclerosis has been well documented [22]. How-
AOPP fraction formed in vivo [17], 1 mL of hemodialy-ever, antioxidant therapeutic strategies have not yet been
sis plasma (or control plasma) was first diluted 1:4 inextensively used in hemodialysis patients, with the excep-
PBS and further submitted to differential centrifugationtion of the recent development of vitamin E–coated dial-
(1000g 20 minutes at 4C) using a 100 kD cutoff centri-ysis membranes. Among potential antioxidant drugs,
con (Amicon, Beverly, MA, USA).N-acetylcysteine (NAC), an aminothiol and synthetic
precursor of cysteine and glutathione, might be a good
Isolation of PMN and monocytecandidate worth testing [23]. Indeed, NAC has already
PMN and monocytes were isolated from ethylenedi-been used therapeutically in several disorders related to
aminetetraacetic acid (EDTA) anticoagulated venousoxidative stress such as chronic bronchitis and acetamin-
blood of healthy controls (N  11) recruited amongophen poisoning, and it has also recently been shown to
volunteer blood donors of the Etablissement du Sangprotect renal function in conditions of acute [24] and
(Paris) and hemodialysis patients (N 16) treated threeCRF [25, 26]. Specifically, NAC is capable of directly
times a week (4- to 5-hour sessions) with dialyzers equi-scavenging ROS and HOCl [27], and after deacetylation,
ped with cellulosic (N  5), or synthetic (N  11) mem-it releases cysteine, which in turn increases the formation
branes. The dialysate was of standard ionic compositionof glutathione, within the intracellular pool of antioxi-
with bicarbonate buffer.dant molecules [28].
Mononuclear cells were obtained by density gradientThe present study conducted in vitro was aimed at (1)
centrifugation over Ficoll-Hypaque 400 (Pharmacia Finecharacterizing the effects of AOPP on monocyte and
Chemicals, Uppsala, Sweden) gradient as described pre-PMN oxygenation activities, and (2) searching whether
viously [29]. Isolation of monocytes from the mono-these effects could be counteracted by NAC both in
nuclear cells, harvested at the interface of the gradient,normal and uremic (hemodialysis patients) phagocytes.
was performed by depletion of nonmonocyte using the
magnetic cell sorting (MACS) cell isolation system (Mil-
METHODS tenyi Biotec, Gladbach, Germany). Briefly, T cells, natu-
If not otherwise indicated, chemicals were purchased ral killer (NK) cells, B cells, dendritic cells, and basophils
from Sigma-Aldrich Chemical Co. (Saint-Quentin Falla- were labeled using a cocktail of hapten-conjugated CD3,
vier, France). CD7, CD19, CD45RA, CD56 and anti-immunoglobulin
E (IgE) antibodies. After washing, labeled cells were
Preparation of AOPP mixed with MACS microbeads coupled to an antihapten
HSA (Calbiochem, San Diego, CA, USA) was ex- monoclonal antibody. Magnetically labeled cells were
posed to HOCl (Fluka, Buchs, Switzerland) to produce depleted by retaining them on a MACS column placed
AOPP [17]. Briefly, HOCl stock solution was freshly in the magnetic field of the VarioMACS, yielding to
a highly purified monocyte suspension (90% to 95%).prepared in phosphate-buffered saline (PBS) and con-
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Monocytes were adjusted at a concentration of 2.5  on the effect of NAC. To quantify the action of NAC,
106cells/mL in phenol-red free Hank’s balanced salt solu- results were expressed as % control CL response 
tion (HBSS) (Eurobio, Paris, France). 100  CL (cells  NAC)  CL (cells  HBSS)/CL
PMN and erythrocytes sedimented through the Ficoll (cells  HBSS).
gradient were resuspended in HBSS to the original vol- The effect of glutathione and dithiothreitol (fc, 5
ume of blood layered on the gradient, mixed in a 2:3 mmol/L for both, previously reported as optimal in [34])
ratio with a 5% solution of Dextran 500 (Pharmacia) was tested in the same conditions as those used for NAC.
in saline and maintained 45 minutes at 4C. The PMN
Statistical analysiscontaining supernatant was then gently aspirated and
centrifuged (200g at 4C for 10 minutes). After lysis of Results were expressed as mean SEM and compared
residual erythrocytes by 1.6% NaCl, PMN (	95%) were using analysis or variance (ANOVA) or Mann-Whitney
resuspended (5  106 /mL) in HBSS. or Wilcoxon tests for unpaired and paired data, respec-
tively. Differences were considered significant when the
NADPH oxidase and myeloperoxidase-dependent
P value was 0.05 or less.
oxygenation activities
Monocyte and PMN NADPH oxidase and myeloperox-
RESULTSidase (MPO)-dependent oxygenation activities were mea-
sured by chemiluminescence (CL) using a single-photon AOPP triggers oxidative responses of PMN in a
luminometer (AutoLumat LB953, Berthold Co., Wild- dose-dependent manner
bad, Germany), as described previously [30]. Briefly, two Both NADPH oxidase, measured by lucigenin-ampli-
distinct activity-specific lipopolysaccharide (LPS) free fied CL, and MPO-dependent activity, measured by lum-
chemiluminogenic substrates obtained from Lumino- inol-amplified CL, of normal PMN were significantly
stix (San Antonio TX, USA) were used: lucigenin (10, increased in a dose-dependent manner with increasing
10-dimethyl-9,9-biacridium dinitrate), which selectively AOPP concentrations (Fig. 1). Most important, there
measures NADPH oxidase–dependent extracellular su- was a linear relationship between HSA-AOPP concen-
peroxide anion formation, and the cyclic hydrazide lumi- trations and lucigenin or luminol CL intensity (r correla-
nol (5-amino-2,3-dihydro–1,4-phthalazinedione), which
tion coefficient of 0.98 and 0.95, respectively).
measures intracellular MPO-dependent formation of
The possibility that LPS contamination contributes to
H2O2 and HOCl [31]. One hundred microliters of PMN the observed effect of HSA-AOPP on PMN oxygenationsuspension (5  105 cells) were distributed into polysty-
activities could be ruled out as follows: (1) LPS concen-rene tubes containing 100 L of a luminigenic substrate
tration as measured by Limulus amoebocyte lysate (LAL)and 50 L of either HBSS (resting CL) or agents to be
test was similar in HSA-AOPP (0.53 EU/mL) and intested, including HSA or HSA-AOPP [final concentra-
HSA (0.58 EU/mL), which itself did not trigger any CLtion (fc) of 2 mg/mL)]; 4-phorbol,12-miristate,13-acetate
response as opposed to HSA-AOPP and as compared(PMA) (fc, 16 mol/L), serum AB opsonized zymosan
to HBSS (Table 1); (2) LPS (from 0.5 EU/mL up to 50(2 109 particles/mL, fc, 2 mg/mL). Luminescence activi-
EU/mL) had no enhancing effect on lucigenin or luminolties were measured in duplicate over 40 minutes and
CL production by PMN as compared to HBSS alone;expressed as integrated total counts.
and (3) polymyxin B did not significantly inhibit HSA-Study of the effect of PMN priming by platelet-activat-
AOPP–induced PMN lucigenin CL [572,850  8582ing factor (PAF) on AOPP-induced activation of NADPH
counts/40 minutes versus 458,100  6380 counts/40 min-oxidase and MPO oxygenation activities was performed
utes, respectively (N  4, NS)] or PMN luminol CLby using PAF (1 g)-coated tubes as described [32] and
response [608,500 counts/40 minutes versus 569,700 following the same steps as above.
8138 counts/40 minutes (N  4, NS].
Effect of NAC and thiol compounds on PMN and
Priming by PAF enhances PMN response capacity tomonocyte oxygenation activities
HSA-AOPPThe effect of NAC on PMN and monocyte oxidative
As previously described [32], PAF-elicited priming ofresponses was tested according to the technical condi-
PMN selectively increased luminol-amplified, but nottions described in [33]. Briefly, 5  105 cells were set to
lucigenin-amplified, CL responses to opsonized zymosanincubate (30 minutes at 37C under constant agitation)
(CR1/CR3 receptor-mediated). In contrast, PAF en-with NAC (fc, 0.01 mg/mL up to 1mg/mL) or HBSS as
hanced HSA-AOPP–induced PMN responses via bothcontrols. It was verified in preliminary experiments that
NADPH oxidase and MPO-dependent pathways, al-(1) 30 minutes was an optimal time of incubation; (2)
though the increase was less pronounced for the formercell viability was not affected up to a 2 mg/mL of NAC;
and (3) washing after cell treatment had no influence than for the latter (Fig. 2).
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Comparative study of PMN and monocyte responses
to HSA-AOPP and to receptor-dependent or
receptor-independent stimuli
NADPH oxidase oxygenation activity. Regardless of the
compound tested, lucigenin-amplified CL production was
higher in PMN than in monocytes. However, the difference
was statistically significant only for stimulated CL (Table
1). For monocytes, HSA-AOPP–induced responses did
not significantly differ from those induced by opsonized
zymosan or PMA. For PMN, HSA-AOPP–induced re-
sponses were also of the same order of magnitude as
those induced by PMA but were significantly higher than
those induced by opsonized zymosan (P 
 0.01).
MPO-dependent oxygenation activity. Likewise, HSA-
AOPP triggered significantly higher luminol-amplified
CL responses than native HSA in both monocyte and
PMN or medium alone (Table 1). However, HSA-
AOPP–induced responses of both monocyte and PMN
remained significantly lower than those induced by opso-
nized zymosan or PMA (P 
 0.001, for both).
NAC inhibits HSA-AOPP–induced oxidative
responses of both PMN and monocytes
Preincubation of monocytes or PMN with NAC (1 mg/
mL) significantly reduced their capacity to elicit HSA-
AOPP–induced responses via either NADPH oxidase
or MPO-dependent pathways (Fig. 4). At a lower con-
centration of 0.1 mg/mL, NAC still inhibited both types
of oxygenation activities of monocyte but not those of
PMN. At a NAC concentration of 0.01 mg/mL, a 30%
increase of both CL responses was observed in PMN but
not in monoctyes. Thus, the dose of 1 mg/mL of NAC
Fig. 1. Dose-dependent effect of human serum albumin-advanced oxi- was used in the following experiments.
dation protein products (HSA-AOPP) on neutrophil nicotinamide ade-
Figure 5 compares the effect of NAC (1 mg/mL) onnine dinucleotide phosphate (NADPH) oxidase and myeloperoxidase
(MPO)-dependent oxygenation activities. The AOPP stock solution HSA-AOPP–mediated CL responses to that on other stim-
was diluted in order to achieve a final protein concentration ranging ulating agents. Whereas NAC inhibited PMA-induced
from 2000 to 62.5 g/mL. Each AOPP dilution was used to trigger
MPO-dependent oxygenation activities of both PMN andpolymorphonuclear nertrophils (PMN) respiratory burst measured by
lucigenin-chemiluminescence (CL) (A ) or luminol-CL (B ). Data from monocytes, it had no effect on PMA-induced NADPH
a typical experiment (reproduced five times) are expressed as integrated oxidase activity of monocytes and an enhancing effectCL responses over 40 minutes (mean SD of duplicate measurements).
on that of PMN. In contrast, regardless of the cell type,
NAC exerted an enhancing effect on opsonized zymo-
san-induced NADPH oxidase and MPO-dependent oxy-PMN respond to plasma-derived AOPP
genation activities. Such an effect was still observed at
Plasma of hemodialysis patients (HD1 and HD2) con- a higher NAC concentration (up to 2 mg/mL) (data not
taining 142 mol/L and 209 mol/L of AOPP, respec- shown).
tively, and a control plasma were enriched in high-molec-
In an attempt to investigate the mechanisms by whichular-weight fractions by differential centrifugation and
NAC may inhibit AOPP-mediated phagocyte activation,tested for their capacity to trigger normal PMN respira-
we tested the effect of thiol-related compounds (e.g.,tory burst (lucigenin CL production). As shown on Fig-
glutathione and dithiothreitol) (both at 5 mmol/L) onure 3, both HD1 and HD2 triggered CL responses as
HSA-AOPP–induced responses of PMN. As shown incompared to a pool of control plasma high-molecular-
Figure 6, both compounds induced a significant inhibi-weight fraction, which itself did not significantly en-
tion of CL response. Interestingly, the inhibition inducedhanced basal CL production. However HD1- or HD2-
by glutathione was of the same order of magnitude asinduced CL responses remained lower than that induced
by HSA-AOPP. that induced by NAC (5 mmol/L), and this was true
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Table 1. Comparative study of monocyte and neutrophil oxygenation activities in healthy subjects
Nicotinamide adeninedinucleotide phosphate (NADPH) oxidase-dependent oxygenation activity
Lucigenin-amplified chemiluminescence (CL) production (mean  SEM, counts/40 minutes) in the presence of
HBSS HSA HSA-AOPP Zymosan PMA
Monocytes (N  6) 11,0915471 97299094 34,52814,033 54,65812,311 42,74715,557
NS NS P  0.009 P  0.05 P  0.005
Neutrophils (N  9) 21,5415535 35,30110,432 271,65079,868 134,41231,655 227,78764,504
Myeloperoxidase (MPO)-dependent oxygenation activity
Luminol-amplified CL production (meanSEM, counts/40 minutes) in the presence of
HBSS HSA HSA-AOPP Zymosan PMA
Monocytes (N  6) 19,2248533 13,6067388 30,48513,076 244,99992,075 107,40936,970
P  0.005 P  0.01 P  0.001 P  0.0002 P  0.003
Neutrophils (N  9) 64,91714,214 62,75628,773 159,40344,681 1,959,833307,264 1,176,958243,746
Abbreviations are: HBSS, Hank’s balanced salt solution; HSA, human serum albumin; HSA-AOPP, human serum albumin–advanced oxidation protein products;
PMA, phorbol myristate acetate. Statistical comparison of differences between monocyte and neutrophil oxygenation activities using Mann Whitney test.
Fig. 2. Effect of platelet-activating factor (PAF) priming on human serum albumin-advanced oxidation protein products (HSA-AOPP)–induced
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and myeloperoxidase (MPO)-dependent oxidative responses of normal neutrophils.
Lucigenin (A, left panel) and luminol (B, left panel) amplified chemiluminescence (CL) production in normal polymorphonuclear neutrophils
(PMN) previously treated (30 minutes at 22C) with PAF or Hank’s balanced salt solution (HBSS) and tested in presence of the indicated agents.
On the left, CL response kinetics (in a representative case). On the right, results of integrated CL production over 40 minutes (mean  SEM of
six experiments).
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ated with uremia. AOPP formed in vitro also behaved
as potent mediators of monocyte activation, triggering
both their respiratory burst and tumor necrosis fac-
tor- (TNF-) synthesis.
In the present study, we show that HSA-AOPP ob-
tained by exposure of HSA to HOCl trigger in a HOCl
dose-dependent manner oxidative responses not only of
monocytes but also of PMN and via both NADPH oxi-
dase and MPO-dependent pathways. In PMN, NADPH
oxidase oxygenation activity triggered by HSA-AOPP
was significantly higher than those induced by comple-
ment opsonized zymosan (which acts via CR1 and CR3Fig. 3. Plasma-derived advanced oxidation protein products (AOPP)
trigger neutrophil respiratory burst. Plasma from two hemodialysis pa- ligation). Like HSA-AOPP, uremic plasma fractions en-
tients (HD1 and HD2) and control plasma were centrifuged in order riched in AOPP obtained by fast protein liquid chroma-to obtain an AOPP-enriched fraction which was used to trigger polymor-
tography (FPLC) also retained the capacity to activatephonuclear neutrophils (PMN) nicotinamide adenine dinucleotide
phosphate (NADPH) oxidase as measured by lucigenin-chemilumines- monocytes. However, this in vitro data should not be
cence (CL). Human serum albumin (HSA)-AOPP was used as positive misinterpreted in the context of uremia. It is highly prob-control. Results of a representative experiment.
able that plasma-derived AOPP also triggered significant
phagocyte activation in vivo, but that inhibitory mecha-
nisms might also counter regulate such proinflammatory
reaction.for both types of oxygenation activities. The inhibition
In contrast to lucigenin, the CL probe luminol usedexerted by dithiothreitol was also similar to that obtained
to measure MPO-dependent activity penetrates insidewith glutathione and NAC upon MPO activity but ap-
the cells and thus mainly measures intracellular oxidantpeared much lower than that upon NADPH oxidase
formation [31, 36]. Surprisingly, intracellular MPO-derivedactivity.
oxygenation activity induced by AOPP was much lower
HSA-AOPP trigger MPO-dependent oxygenation than that obtained with opsonized zymosan or PMA,
activity of uremic PMN regardless of the cell type. Taking into account the fact
that PMN could be activated by LPS, it was verified thatAs shown in Table 2, both basal and stimulated CL
AOPP-induced respiratory burst was not due to LPSproductions were higher in hemodialysis patients than in
contamination, thus definitively ruling out an artifact.healthy subjects (shown in Table 1). Unlike with control
These observations support our working hypothesisPMN (shown in Fig. 1), PAF pretreatment of uremic
that AOPP behave as mediators of inflammation, which,PMN did not significantly influence opsonized zymosan-
however, still need to be precisely defined. Indeed, likeinduced MPO oxygenation activity, in keeping with an
AGE, which under their name comprise a wide varietyalready primed state [32]. In contrast, such a treatment
of heterogeneous compounds [37], AOPP might also besignificantly enhanced HSA-AOPP–induced responses
considered not as single species but rather as a familyof hemodialysis patient PMN (by 117%).
of compounds. Among these, both dityrosine and car-Surprisingly, PAF induced a profound decrease in
bonyls, which are produced following exposure of albu-basal CL production and this was not due to loss of cell
min to HOCl [15, 18, 21] were found to be present inviability (95% of viable PMN after PAF treatment).
our HOCl-modified HSA preparation, and in our in vivo
NAC selectively inhibits HSA-AOPP–induced study of a cohort of uremic patients were closely corre-
MPO-dependent oxidative response of uremic PMN lated to AOPP levels [19]. Interestingly, in these previous
studies we also observed that these protein oxidationNAC (1 mg/mL) significantly reduced HSA-AOPP–
derivatives were not, when tested alone, capable to trig-induced luminol-amplified CL response of unprimed as
ger monocyte respiratory burst, as was the whole AOPPwell as of PAF-primed PMN. In contrast, NAC had no
preparation. This observation does not rule out the pos-effect on opsonized zymosan-induced CL response (Ta-
sibility that other HOCl-mediated albumin oxidationble 2).
products compounds (e.g., oxidized fatty acids or reac-
tive aldehydes attached to HSA, and protein nitration-
DISCUSSION derived products) could as single exert such an effect
Our previous studies (recently reviewed in [35]) have and their proper contribution to AOPP biochemical
led us to identify AOPP as novel markers of oxidative composition and mediated biologic effects remains to be
damage to proteins and novel mediators of inflammation, determined.
Our results showing that AOPP generated in vivo andnotably involved in the monocyte activation state associ-
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Fig. 4. Dose-dependent effect of N-acetyl-
cysteine (NAC) on human serum albumin-
advanced oxidation protein products (HSA-
AOPP)–induced monocyte and neutrophil
NADPH-oxidase and MPO-dependent oxi-
dative responses. HSA-AOPP–induced mono-
cyte (A ) and neutrophil (B ) nicotinamide
adenine dinucleotide phosphate (NADPH)
oxidase [lucigenin-amplified chemilumines-
cence (CL) responses, top panels] and mye-
loperoxidase (MPO)-dependent oxygenation
activities (luminol-amplified CL responses,
bottom panels) were measured after cell incu-
bation (30 minutes at 37C) with Hank’s bal-
anced salt solution (HBSS) or NAC at the
indicated concentrations. Results (mean 
SEM of six experiments) were expressed as
% control CL response  100  CL (cells 
NAC)  CL (cells  HBSS)/CL (cells 
HBSS).
Fig. 5. Comparative effect of N-acetylcys-
teine (NAC) (1 mg/mL), opsonized zymosan,
and phorbol myristate acetate (PMA) on hu-
man serum albumin-advanced oxidation pro-
tein products (HSA-AOPP)–induced mono-
cyte and neutrophil nicotinamide adenine
dinucleotide phosphate (NADPH) oxidase and
myeloperoxidase (MPO)-dependent oxidative
responses. Monocyte (A ) and neutrophil (B )
NADPH oxidase [lucigenin-amplified chemi-
luminescence (CL) responses, top panels] and
MPO-dependent oxygenation activities (lumi-
nol-amplified CL responses, bottom panels)
triggered by HSA-AOPP, opsonized zymo-
san, or PMA were measured after cell incuba-
tion (30 minutes at 37C) with Hank’s bal-
anced salt solution (HBSS) or NAC (1 mg/
mL). For each stimulus, results (mean SEM
of six experiments) were expressed as % con-
trol CL response 100CL (cellsNAC)
CL (cells  HBSS)/CL (cells  HBSS).
extracted from uremic plasma are capable to trigger neu- dent activity is also in favor of our working hypothesis
that these products as numerous mediators may by them-trophil respiratory burst in a similar manner as does
HOCl-treated control plasma are in support of their selves amplify their own formation.
We also showed that PMN priming by PAF enhancesphysiopathologic relevance for the phagocyte activation
associated with uremia. Since AOPP are preferentially their potential to mount oxidative responses to AOPP.
PAF has been found to trigger up-regulation of CR1,formed by chlorinated oxidants [17, 19] and MPO is the
sole enzyme capable of producing such oxidants in vivo, CR3, and FcRII, the receptors ligated upon opsonized
zymosan stimulation [32, 38, 39]. Since the ligation ofthis AOPP-induced activation of neutrophil MPO-depen-
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Fig. 6. Comparative effect of N-acetylcysteine (NAC), glutathione
(GSH) and dithiothreitol (DTT) on human serum albumin-advanced
oxidation protein products (HSA-AOPP)–induced neutrophil nicotin-
amide adenine dinucleotide phosphate (NADPH) oxidase and myelo-
peroxidase (MPO)-dependent oxidative responses. Neutrophil NADPH
oxidase [lucigenin-amplified chemiluminescence (CL) responses] (A )
and MPO-dependent oxygenation activities (luminol-amplified CL re-
sponses) (B) triggered by HSA-AOPP were measured after cell incuba-
tion (30 minutes at 37C) with either Hank’s balanced salt solution
(HBSS) or NAC or GSH or DTT at 5 mmol/L. For each stimulus,
(mean  SEM of six experiments) were expressed as % control CL
response 100 CL (cells NAC) CL (cellsHBSS)/CL (cells
HBSS).
opsonized zymosan with opsonin receptors induces rapid
receptor internalization, up-regulation of opsonin recep-
tors by PAF results in a selective increase in intracellular
oxidants, as evidenced by enhanced MPO-derived activi-
ties, without increasing extracellular superoxide produc-
tion. In contrast, PAF did not increase PMA-induced
respiratory burst because it is receptor independent. In-
terestingly, PAF significantly increased AOPP-induced
extracellular superoxide anion release and intracellular
MPO activities, thus suggesting that AOPP triggers re-
spiratory burst via the ligation of a specific receptor,
which is distinct from opsonin receptor. This receptor
might be stored within intracellular pools, but would
be easily mobilizable toward the plasma membrane We
therefore hypothesized that AOPP-induced respiratory
burst could be a pertinent parameter to be modulated
via appropriate therapeutic strategies aimed at reducing
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oxidative stress in hemodialysis patients. In this context,
Witko-Sarsat et al: Effect of N-acetylcysteine on AOPP-induced monocyte and neutrophil activation90
NAC was chosen as a candidate for antioxidant therapy. AOPP as a most relevant index of phagocyte-derived
Regardless of cell type, NAC at a dose of 0.5 to 1 mg/mL oxidative stress and associated cardiovascular complica-
inhibited AOPP-induced oxygenation activities via both tions, not only in uremic patients [41] but also in nonure-
NADPH oxidase and MPO-dependent pathways. With mic patients with coronary disease [42]. Interestingly, in
regard to other stimulating agents we also found that, our own study, AOPP but not another oxidative stress
while NAC did not inhibit NADPH oxidase activation marker such as malondialdehyde (MDA) were found to
induced by PMA, it reduced MPO-dependent activity be an independent risk factor for atherosclerosis and
of both PMN and monocytes. In contrast, NAC had no AOPP were highly correlated with ferritin.
inhibitory effect and even exerted an enhancing effect, Thus, antioxidant administration seems a promising
on both opsonized zymosan-induced types of oxygen- approach [43] to prevent oxidative stress-related compli-
ation activities. As opposed to PMA, which activates cations in end-stage renal disease (ESRD) patients [9,
phagocyte oxidative metabolism via a receptor-indepen- 14, 22]. Among the numerous antioxidants tested, there
dent pathway, opsonized zymosan triggers phagocyte ox- is a great deal of recent evidence to suggest that NAC
idative responses via CR1 and CR3 receptor-dependent administration may protect renal function [24–26].
pathways [31]. Interestingly, an enhancing effect of NAC AOPP-induced respiratory burst appears to be a
on the phagocytic activity of neutrophils has been ob- promising target for modulating the inflammatory state
served [40]. in CRF. More important, the fact that the effect of NAC
The inhibitory effect of NAC on AOPP- and PMA- differs according to the stimulating agent and the intra-
induced but not on opsonized zymosan-induced respira- cellular signaling is of special relevance in the context
tory burst strongly suggests that NAC acts via the modu- of therapeutic intervention. Indeed, our results are in
lation of intracellular signaling, and not via a nonspecific keeping with the hypothesis that, in vivo, NAC will selec-
intracellular oxidant scavenging effect. Of note, both tively inhibit oxygenation activities triggered by AOPP,
glutathione and dithiothreitol, which, like NAC, also a circulating inflammatory mediator, without decreasing
act mainly intracellularly and upon signal transduction intracellular oxidants, which are induced via the ligation
pathways [34], exerted a similar inhibitory effect on of opsonin receptors, and required for host defense. Clin-
AOPP-induced PMN oxygenation activities. Of interest ical trials should be developed in order to verify whether
is the consideration that signaling involved in AOPP
this new indication of an old drug is relevant and whetherand in PMA-induced respiratory burst might share some
NAC can be useful in the treatment of uremic patients.common steps since they are both inhibited by NAC,
whereas opsonized zymosan-induced respiratory burst is
not. Although NAC did not inhibit opsonized zymosan- NOTE ADDED IN PROOF
induced respiratory burst, we cannot rule out that NAC During the publication process of this paper, Tepel
might interfere, in vivo, with some mechanisms involved et al [44] reported that the oral administration of NAC
in host defense. to chronic hemodialysis patients over 14.5 months was
The last part of our study, which was conducted with
associated with a significant reduction of cardiovascularPMN of a homogeneous series of dialysis patients,
events, in keeping with the probable clinical relevanceshowed that basal luminol-amplified CL is much higher
of our study.than those of controls. This suggests that PMN of hemo-
dialysis patients are in a primed state. As to the effect
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